Hematological Cancer News

Get the latest cancer news and research. Sort by cancer type or read the current headlines to learn what’s happening in the science of cancer detection and treatment, as well as healthy living tips for dealing with cancer.

Nov

05

Sweet Potatoes Make For A Hearty Soup Base

It's a safe bet to presume there are soup recipes in today's column because it's colder, furnaces are running and it just seems like a fall thing to do.

Nov

04

Stuffed Acorn Squash Makes A Hearty Entree

Mollie Katzen's latest cookbook urges beginners to take on her challenge with easy recipes, such as this acorn squash entree. Use plain raw almonds, not roasted or salted, Katzen writes, and don't chop them too fine. You can cook the rice and bake the acorn squash at the same time.

Nov

04

Light Stews Still Hearty: Reduce Fat And Salt In Fall Soups

If you're watching your weight, soup can be deceptive. What could be more harmless for lunch or a light dinner? Not so fast. Depending on the recipe, some soups are full of cream and cheese, or sometimes worse, they start with a roux. In place of cream and butter, add flavor to soup with lots of vegetables, beef broth and dried and fresh herbs.

Oct

31

Coffee Brims With Health Benefits, Researchers Say

Drink up, coffee lovers. Not only is coffee aromatic and delicious, it's good for you. Who says? None other than Harvard Medical School. Once considered questionable for your health, it turns out that the beloved beverage is actually healthful in moderation. That means a few cups a day.

Oct

30

Exercise Helps Lymphoma Patients

Canadian researchers say aerobic exercise benefits lymphoma patients -- even those on chemotherapy. The study, published in the Journal of Clinical Oncology, finds lymphoma patients who received exercise intervention reported significantly improved physical functioning, overall improved quality of life, less fatigue, increased happiness, less depression and an improvement in lean body mass.

Oct

29

FDA Approves Elitek For Management Of Plasma Uric Acid Levels In Adults With Leukemia, Lymphoma, And Solid Tumors Receiving Anti-Cancer Therapy

Sanofi-aventis U.S. announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Elitek (rasburicase) to be used for the initial management of plasma uric acid (PUA) levels in adult patients with leukemia, lymphoma, and solid tumor malignancies who are receiving anti-cancer therapy expected to result in tumor lysis syndrome (TLS) and subsequent elevations of plasma uric acid.

Oct

27

FDA Approves New Treatment For Chronic Lymphocytic Leukemia

The U.S. Food and Drug Administration today approved Arzerra (ofatumumab) for patients with chronic lymphocytic leukemia (CLL), a slowly progressing cancer of the blood and bone marrow.

Oct

25

Cut Your Cancer Risk: Add Fruits And Veggies To Your Diet

Eating lots of fruits and vegetables can help reduce your cancer risk. That's one reason the American Cancer Society recommends eating at least five servings of these foods every day.

Oct

22

Chronic Pain Treatments Work Better Together, Says Anesthesiologist

People who suffer from debilitating neuropathic pain may get more relief and sleep better by combining two commonly-prescribed drugs. A new, federally-funded study by Queen's University researchers has found that taking the drugs together is a more effective treatment than taking either of them individually.

Oct

21

Millennium Initiates Phase II Trial For Diffuse Large B-Cell Lymphoma

Millennium: The Takeda Oncology Company today announced the initiation of a Phase II clinical trial examining rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) with or without VELCADE(R) (bortezomib) for Injection for patients with a common type of lymphoma. The study will examine previously untreated patients with a genomically defined subtype of lymphoma called non-germinal center B- cell-like (non-GCB) diffuse large B-cell lymphoma.

Page(s): Prev 1 2 3 4 5 6 7 ...155156 Next 

We care about your feedback. Let us know how we can improve your CancerCompass experience.